CORVUS PHARMACEUTICALS

Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03 9 2024 13:05:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

30 8 2024 06:54:02 提供 NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

26 8 2024 06:45:13 提供 NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

20 8 2024 06:45:10 提供 NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

19 8 2024 06:45:26 提供 NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

16 8 2024 12:51:52 提供 NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

09 8 2024 07:13:40 提供 NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

08 8 2024 09:16:24 提供 NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

07 8 2024 06:45:01 提供 NetDania Notify

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results

06 8 2024 13:01:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

02 8 2024 06:45:18 提供 NetDania Notify

Corvus Pharmaceuticals Granted FDA Fast Track Designation for Soquelitinib for Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

01 8 2024 05:30:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2024 Financial Results on August 6, 2024

31 7 2024 05:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

30 7 2024 06:55:53 提供 NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

29 7 2024 09:38:28 提供 NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

26 7 2024 08:47:58 提供 NetDania Notify

Publication of Preclinical Data in Science Signaling Demonstrated the Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Treatment of Inflammatory Diseases

25 7 2024 05:30:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference

30 5 2024 13:02:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results

06 5 2024 13:01:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024

02 5 2024 13:02:00 提供 Nasdaq GlobeNewswire